healthcare communications and market access consultancies.
We work in the UK and across the EMEA region.
Examples of our work include:
advising and managing market access teams for the launch of new medicines in ultra-rare diseases and cancer, including NICE Technology Appraisals, Highly Specialised Technologies, and NHS England specialised commissioning processes;
undertaking an organisational and strategic review of government affairs departments for a major pharmaceutical company across EMEA;
refreshing a campaign plan for a major national patient charity to improve public awareness and achieve policy change;
securing public funding for a national clinical audit to improve patient care and outcomes;
stimulating partnership projects between pharmaceutical companies and the NHS to improve patient outcomes and the management of chronic diseases;
providing board-level advice on the impact of Brexit on the life sciences sector to the leaders of ten healthcare companies.